Cargando…
Cathepsin D improves the prediction of undetected diabetes in patients with myocardial infarction
Background: Newer therapeutic agents for type 2 diabetes mellitus can improve cardiovascular outcomes, but diabetes remains underdiagnosed in patients with myocardial infarction (MI). We sought to identify proteomic markers of undetected dysglycaemia (impaired fasting glucose, impaired glucose toler...
Autores principales: | Velders, Matthijs A., Calais, Fredrik, Dahle, Nina, Fall, Tove, Hagström, Emil, Leppert, Jerzy, Nowak, Christoph, Tenerz, Åke, Ärnlöv, Johan, Hedberg, Pär |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7182365/ https://www.ncbi.nlm.nih.gov/pubmed/31429631 http://dx.doi.org/10.1080/03009734.2019.1650141 |
Ejemplares similares
-
Nondipping blood pressure pattern predicts cardiovascular events and mortality in patients with atherosclerotic peripheral vascular disease
por: Dahle, Nina, et al.
Publicado: (2023) -
Poorly controlled ambulatory blood pressure in outpatients with peripheral arterial disease
por: Dahle, Nina, et al.
Publicado: (2021) -
Are the results from a multiplex proteomic assay and a conventional immunoassay for NT-proBNP and GDF-15 comparable?
por: Skau, Emma, et al.
Publicado: (2023) -
Temporal Trends in the Prevalence of Cancer and Its Impact on Outcome in Patients With First Myocardial Infarction: A Nationwide Study
por: Velders, Matthijs A., et al.
Publicado: (2020) -
Multiplex proteomics for prediction of major cardiovascular events in type 2 diabetes
por: Nowak, Christoph, et al.
Publicado: (2018)